Global ph 3, randomized, double-blind, placebo-controlled study of PEGylated recombinant human hyaluronidase PH20 (PEGPH20) + nab-paclitaxel & gemcitabine in pts with previously untreated, hyaluronan-high, stage iv pancreatic ductal adenocarcinoma

Autor:	Tara Elisabeth Seery, Michel Ducreux, C.-P. Li, Pippa Corrie, Andrea J. Bullock, Michele Reni, Y.-J. Bang, E. Van Cutsem, William P. Harris, Dimitrios Chondros, Andrew Eugene Hendifar, Lei Zheng, D-Y. Oh
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty Pancreatic ductal adenocarcinoma business.industry Placebo-controlled study Hematology Gemcitabine Double blind Internal medicine medicine In patient Pegylated Recombinant Human Hyaluronidase PH20 business Stage iv medicine.drug Nab-paclitaxel
Zdroj:	Annals of Oncology. 28:iii24
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx261.042
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::99fa481bbebe386656ee8ba604f8c256 https://doi.org/10.1093/annonc/mdx261.042 Zobrazit plný text záznamu